US Edition
News from Pharmaceutical Business review
Information about Pharmaceutical Business Review
Where is Pharmaceutical Business Review located?Pharmaceutical Business Review's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmaceutical Business Review News
Pharma · United StatesNew York, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today called the U.S. Food and Drug Administration’s approval of Itvisma (onasemnogene abeparvovec-brve), developed by Novartis, a major step forward for families living with spinal muscular atrophy…See the Story
Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (Onasemnogene ...
61% Center coverage: 23 sources
Texas Politics · TexasPfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program over alleged quality control lapses in a medicine to treat attention deficit hyperactivity disorder in children.See the Story
Pfizer in $41.5 million settlement with Texas over ADHD drug for children
67% Center coverage: 9 sources
